Stock DNA
Software Products
USD 13,620 Million (Small Cap)
53.00
NA
0.00%
-1.10
-999,999.00%
9.02
Revenue and Profits:
Net Sales:
304 Million
(Quarterly Results - Dec 2025)
Net Profit:
-227 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-22.67%
0%
-22.67%
6 Months
-64.51%
0%
-64.51%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Figma, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
44.60%
EBIT Growth (5y)
-494.55%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
65.96%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
53
Industry P/E
Price to Book Value
3.11
EV to EBIT
61.18
EV to EBITDA
55.06
EV to Capital Employed
-15.03
EV to Sales
3.16
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
5.86%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Mildly Bearish
KST
Dow Theory
No Trend
Bearish
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 32 Schemes (5.21%)
Foreign Institutions
Held by 103 Foreign Institutions (18.65%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
303.80
274.20
10.80%
Operating Profit (PBDIT) excl Other Income
-189.50
-1,132.40
83.27%
Interest
0.00
0.00
Exceptional Items
-22.40
7.70
-390.91%
Consolidate Net Profit
-226.60
-1,097.00
79.34%
Operating Profit Margin (Excl OI)
-643.60%
-4,146.20%
350.26%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 10.80% vs 9.86% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 79.34% vs -1,37,225.00% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,055.80
749.00
40.96%
Operating Profit (PBDIT) excl Other Income
-1,274.90
-869.70
-46.59%
Interest
0.00
0.00
Exceptional Items
-0.80
23.80
-103.36%
Consolidate Net Profit
-1,250.50
-732.10
-70.81%
Operating Profit Margin (Excl OI)
-1,222.30%
-1,171.50%
-5.08%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 40.96% vs 48.35% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -70.81% vs -356.07% in Dec 2024






